The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial

OBJECTIVE: To develop a frailty index (FI) and explore the relationship of frailty to subsequent adverse outcomes on the effectiveness and safety of more intensive control of both blood glucose and blood pressure (BP), among participants with type 2 diabetes in the Action in Diabetes and Vascular Di...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Tu N., Harris, Katie, Woodward, Mark, Chalmers, John, Cooper, Mark, Hamet, Pavel, Harrap, Stephen, Heller, Simon, MacMahon, Stephen, Mancia, Giuseppe, Marre, Michel, Poulter, Neil, Rogers, Anthony, Williams, Bryan, Zoungas, Sophia, Chow, Clara K., Lindley, Richard I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Emerging Therapies: Drugs and Regimens
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323181/
https://www.ncbi.nlm.nih.gov/pubmed/34035077
http://dx.doi.org/10.2337/dc20-2664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323181/
https://www.ncbi.nlm.nih.gov/pubmed/34035077
http://dx.doi.org/10.2337/dc20-2664

Ejemplares similares